Y, L., X, Y., J, L., X, L., & S, W. (2019). CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients. Dove Medical Press.
Style de citation Chicago (17e éd.)Y, Lin, Yang X, Lv J, Liu X, et Wang S. CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients. Dove Medical Press, 2019.
Style de citation MLA (8e éd.)Y, Lin, et al. CXCL13 Is A Biomarker Of Anti-Leucine-Rich Glioma-Inactivated Protein 1 Encephalitis Patients. Dove Medical Press, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.